Formulation Featured Articles
-
Rapid Mycoplasma Testing Service Delivers Speed, Sensitivity And Specificity To A Broad Scope Of Sample Matrices
10/17/2012
Mycoplasma are the smallest known self-replicating prokaryotes. They parasitize a wide range of host organisms, including humans, animals, plants and insects and are common contaminants of mammalian cell culture. By Dr. Jeri Ann Boose, director, Biopharmaceutical Services, and Dr. Weihong Wang, manager, Molecular & Cell Biology Services
-
GE Healthcare Launches Ni Sepharose Excel Chromatography Media For Direct Purification Of Histidine-Tagged Proteins Secreted From Eukaryotic Expression Systems
8/21/2012
GE Healthcare’s Ni Sepharose excel is an immobilized metal ion affinity chromatography (IMAC) medium (resin) for the direct capture and purification of secreted histidine-tagged recombinant proteins from eukaryotic cell culture supernatants.
-
New HQ For Lab M Heralds Exciting Phase In Company’s Development
5/30/2012
Lab M’s move into new global headquarters, in June 2012, represents the most significant investment in the microbiology company’s more than 40-year history.
-
3M Purification Inc. Introduces New Zeta Plus Encapsulated, Single-Use Depth Filtration Products
5/4/2012
3M Purification Inc. has expanded its portfolio of Encapsulated Zeta Plus single-use depth filtration capsules. The two new product lines – Zeta Plus Scale-up Capsule Filters and new single-layer media grades for Zeta Plus Encapsulated capsules – are designed with our industry leading Zeta Plus depth filter media, designed for applications in the bio-pharmaceutical industry including cell culture clarification, downstream process protection, virus, DNA and lipid reduction, and host cell protein (HCP), protein aggregate, endotoxin and anti-foaming agent removal.
-
Market Research Projects Media, Sera & Reagents Markets In Biotechnology At $4.2B By 2016
4/24/2012
MarketResearch.com has announced the addition of the new report "Global Markets for Media, Sera and Reagents in Biotechnology," to their collection of Biotechnology market reports.
-
Turbulent Mixing: Scaling Up Nanoparticle Manufacturing For The Future
Choosing between turbulent and microfluidic mixing methods in your lipid nanoparticle (LNP) production can have a significant impact when scaling up production.
-
Raw Materials Risk Mitigation And Management
Protecting your raw materials is a vital part of your process – and one that should be taken seriously. Repercussions like plant shut-downs and drug shortages — stemming from events like virus contamination — can be far-reaching and difficult to overcome. To help safeguard your product, and to avoid potential adverse events, you can keep the following things in mind when sourcing media.
-
Complex Carbohydrate Chemistry: A Key To Addressing Unmet Medical Needs
Carbohydrates have been shown to play a fundamental role in normal cell functions as well as in major disease pathologies including cancer, cardiovascular disease and inflammatory diseases. As a class of molecules, carbohydrates have an enormous range of shape, orientation and composition. Due to this structural diversity, carbohydrate chemistry can be applied to develop a broad range of complex therapeutic molecules and drugs, including pure carbohydrates as well as protein-linked carbohydrates, or glycoproteins. However, as a consequence of their structural complexity, carbohydrates have not received as much scientific attention as nucleic acids and proteins. However, significant progress is being made in this area.
-
Mechanisms Of LNP-Mediated mRNA Delivery
Explore the details supporting LNP-mediated mRNA delivery, as well as the challenges facing mRNA based therapeutics in the future.
-
Avoiding The Pitfalls Of LNPs And Complex Formulations
Explore the necessary components of a smooth tech transfer for LNP-based drugs, including the variables that impact LNP formulation and the outsourcing strategies needed to avoid common pitfalls.